Newsfeed First Patient Enrolled in Tryton Post Approval StudyJanuary 25, 2018Tryton Medical announces new CEO and presidentJanuary 3, 2018Innovative Tryton Side Branch Stent Recognized with the Premier Technology Breakthrough AwardSeptember 19, 2017Tryton Medical Announces First U.S. Commercial Case with Tryton Side Branch StentMarch 21, 2017Tryton Medical Receives FDA Approval for Tryton Side Branch Stent to Treat Significant Coronary Bifurcation LesionsMarch 6, 2017Tryton Medical Enters Into Strategic Agreement with Cardinal HealthOctober 28, 2016Tryton Medical Announces Clinical Symposium on Treatment of Complex Bifurcation Lesions at TCT 2016October 17, 2016Outcomes from Tryton Medical Pivotal Confirmatory Study Published in JACC Cardiovascular InterventionsJuly 5, 2016Tryton Medical Files Pre-Market Approval Application with US FDA for Tryton Side Branch StentNovember 2, 2015Tryton Meets Primary Endpoint in Pivotal Confirmatory Study of Tryton Side Branch Stent in Treatment of Coronary Bifurcation LesionsOctober 12, 2015View all Press Releases
Innovative Tryton Side Branch Stent Recognized with the Premier Technology Breakthrough AwardSeptember 19, 2017
Tryton Medical Receives FDA Approval for Tryton Side Branch Stent to Treat Significant Coronary Bifurcation LesionsMarch 6, 2017
Tryton Medical Announces Clinical Symposium on Treatment of Complex Bifurcation Lesions at TCT 2016October 17, 2016
Outcomes from Tryton Medical Pivotal Confirmatory Study Published in JACC Cardiovascular InterventionsJuly 5, 2016
Tryton Medical Files Pre-Market Approval Application with US FDA for Tryton Side Branch StentNovember 2, 2015
Tryton Meets Primary Endpoint in Pivotal Confirmatory Study of Tryton Side Branch Stent in Treatment of Coronary Bifurcation LesionsOctober 12, 2015